Agreements Relating to the Transfer of the Mioxal Product, dated as of November 7, 2022, by and between Innovation1 Biotech Inc. and Ingenius Biotech S.L

EX-10.1 2 ivbt_ex101.htm AGREEMENT ivbt_ex101.htm

EXHIBIT 10.1